Dr. Marron presents an overview of immunology, the current state of cancer immunotherapy, and approaches to moving the field forward. This includes creating an immune atlas of tumors in order to facilitate comparing responders to non-responders and developing rational combinatorial approaches. Dr. Marron also discusses deep tumor immunophenotyping as an aid in target selection, a process that is supported by Mount Sinai’s unique immune monitoring platform and expertise.
Related Presenters
Director, Early Phase Trials Unit, The Tisch Cancer Institute
Professor of Medicine
Professor of Immunology and Immunotherapy
Icahn School of Medicine at Mount Sinai
Related Videos
